Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: ScienceDaily

What happened

Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders.

Key facts

  • Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders.
  • Reported by ScienceDaily and published Wed, 07 Oct 2026 12:13:35 UTC.

Why it matters

Research findings and mission results set the evidence base that policy, funding and later discoveries build on.

What to watch next

  • Peer review status and replication of the findings
  • Mission milestones and next scheduled attempt
  • Funding or policy decisions that follow

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. What happens in the brain when cannabis makes you anxious?

  2. The world's oyster reefs could add $12 trillion to planetary health each year—if they were better managed

  3. Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s

Sources

The original report was published by ScienceDaily. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at ScienceDaily

Related WorldPing coverage

ScienceDaily
WorldPing
ScienceDaily

What happens in the brain when cannabis makes you anxious?

Cannabinoids may intensify anxiety by removing a natural brake on specific neurons in the brain’s fear center, particularly during stressful situations. In mice, shutting down those neurons sharply reduced cannabinoid-related anxious behavior.

Brief by WorldPing · Original reporting by ScienceDaily